Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.88 | N/A |
| PEG Ratio (TTM) | 0.16 | N/A |
| P/S Ratio (TTM) | 5.56 | N/A |
| P/B Ratio (TTM) | 3.86 | N/A |
| P/FCF Ratio (TTM) | 13.62 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.13 | N/A |
| Price to 5YR AVG FCF Ratio | 64.00 | N/A |
Profitability (95%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 18.50% | N/A |
| ROE (TTM) | 25.74% | N/A |
| Net Profit Margin (TTM) | 31.01% | N/A |
| ROIC 5YR AVG | 93.18% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 63.78% | 92.99% | 74.65% |
| Revenue | 6.55% | 6,798.64% | 4,106.79% |
| Net Income | 65.73% | 93.88% | 75.60% |
| Cash Flow | 23.80% | 99.61% | 82.96% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.11 | N/A |
| Quick Ratio (TTM) | 4.92 | N/A |
| D/E Ratio (TTM) | 0.00 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 16.33 | N/A |
| LTL to 5YR AVG FCF | 0.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.71% | N/A |